Quick Search
Filters Clear All
Any Time
- 2026
- 2025
- 2024
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
Product Category
- Antibiotics
- Balanced Salt Solutions
- Cell Dissociation Reagents
- Cell Freezing Media
- Cell Health Assays
- Cell Identification Service
- Cell Lines
- Complete Growth Media
- Cytokines
- Exosome Isolation Kits
- Growth Supplements
- Induced Differentiation Media
- Liquid Basal Media
- Other Reagents
- Powder Basal Media
- Primary Cell Isolation and Culture Kit
- Primary Cells
- Removal Media
- Removal Reagents
- Serum
- Serum-Free Media
Country
- Angola
- Argentina
- Australia
- Austria
- Bangladesh
- Barbados
- Belarus
- Belgium
- Brazil
- Bulgaria
- Burkina Faso
- Burundi
- Cambodia
- Cameroon
- Canada
- Chile
- China
- Chinese Taiwan
- Congo
- Croatia
- Cyprus
- Czech
- Czechia
- Denmark
- Egypt
- Estonia
- Ethiopia
- Finland
- France
- Gabon
- Germany
- Ghana
- Greece
- Hungary
- India
- Indonesia
- Iran
- Iraq
- Ireland
- Israel
- Italy
- Japan
- Kazakhstan
- Kenya
- Korea
- Kuwait
- Kyrgyzstan
- Luxembourg
- Malaysia
- Mexico
- Mongolia
- Morocco
- Mozambique
- Myanmar
- Nepal
- Netherlands
- New Zealand
- Nigeria
- Norway
- Pakistan
- Philippines
- Poland
- Portugal
- Romania
- Russia
- Saudi Arabia
- Singapore
- Slovenia
- Somalia
- South Africa
- South Korea
- Spain
- Sri Lanka
- Sudan
- Sweden
- Switzerland
- Syria
- Thailand
- Tunisia
- Turkey
- UAE
- UK
- USA
- Uganda
- Ukraine
- United Kingdom
- Uruguay
- Uzbekistan
- Vietnam
Publications
Procell has assisted our customers in publishing 32,193 papers in SCI-indexed journals, including leading journals such as Nature Medicine, Nature, Cell, Science, and Signal Transduction and Targeted Therapy.
Filter
-
Efficient amyloid-β degradation in Alzheimer’s disease using SPYTACs (2026-03-04)
-
Remodeling of the tumor microenvironment in muscle-invasive bladder cancer: insights from single-cell and spatial transcriptomics after neoadjuvant immunochemotherapy (2026-07-17)
Journal: Molecular Cancer (2026) IF: 42.2Products Cited: Fetal Bovine Serum -
Predicting small molecule–RNA interactions without RNA tertiary structures (2026-01-02)
-
Sustained nitric oxide production by engineered E. coli remodels the tumor microenvironment and potentiates immunotherapy (2026-03-18)
-
Lysosome self-sorting nanodegraders for hepatic clearance of pathogenic serum mediators (2026-07-09)
-
Computationally guided design of bioactive nanostructures for targeted clearance of amyloid-β aggregates in Alzheimer’s disease (2026-07-21)
Journal: Nature Nanotechnology (2026) IF: 37.5Products Cited: DMEM (High glucose) Medium, Mouse Hippocampal Neurons -
Nanoparticles reach metastatic tumours via enhanced permeability of adjacent vessels (2026-06-12)
Journal: Nature Nanotechnology (2026) IF: 37.5Products Cited: Mouse Liver Sinusoidal Endothelial Cell Complete Medium, Mouse Liver Sinusoidal Endothelial Cells -
Enhancing antitumour nanovaccine efficacy via integrated cholesterol modulation in situ (2026-04-16)
-
Tumour-infiltrating microplastics disrupt the JAK-STAT-microbiota axis to promote immunotherapy resistance in colorectal cancer (2026-02-10)
-
LncRNA NEAT1 promotes immunosuppression in gastric cancer under endoplasmic reticulum stress by maintaining the M6A methylation of SEMA3A in CAFs (2026-03-04)
Journal: Molecular Cancer (2026) IF: 33.9Products Cited: Human Gastric Cancer Fibroblast Complete Medium, Human Gastric Cancer Fibroblasts
